Biomedical big data company GENALICE has added a cloud solution to its on-premise solution, the GENALICE VAULT, via Amazon Web Services (AWS). It is said to include the same functionality, accuracy, speed and footprint reduction as the GENALICE VAULT. [ + ]

Professor Ian Chubb AC will continue as Australia's Chief Scientist until the end of 2015.

Innovation is key for Australian businesses to remain competitive according to the latest Australian Innovation System Report, which has been released by the office of the Chief Economist and the Department of Industry and Science. [ + ]

A new South Australian science club, launched at The University of Adelaide, will fill the gap left by the closure of the CSIRO's Double Helix Science Club following federal government funding cuts. [ + ]

Phosphagenics (ASX:POH) has put its bioElixia range of cosmetic products up for sale as part of plans to focus on its core drug delivery business.

Phylogica (ASX:PYC) has been issued a notice of allowance for an EU patent covering using its Phylomer peptide libraries for drug discovery screening.

ASTM International has proposed a standard which will function as a template that helps companies analyse how any one chemical's use has social, economic and ecological implications at each stage of a product's life cycle. [ + ]

AusBiotech has made a submission to IP Australia on the draft IP Toolkit for research collaborations between research institutes and companies, where it said the draft IP Toolkit could offer useful guidance to SMEs who wish to engage in collaborations.

The vice-chancellor and president of the University of Western Sydney (UWS), Professor Barney Glover, has been appointed the next chair of Universities Australia (UA) - the peak body representing the Australian university sector both nationally and internationally. [ + ]

Surgeons in Sydney have successfully replaced leaky mitral valves in two human hearts while they were still beating. [ + ]

Patrys (ASX:PAB) has secured a third European patent - its ninth globally - covering PAT-SM6, an anticancer candidate with potential applications in a wide range of cancers.

Scientific equipment supplier AXT has announced a partnership with atomic force microscope (AFM) manufacturer NT-MDT. The agreement will see AXT represent NT-MDT in Australia and New Zealand, looking after both sales and service. [ + ]

Scientific equipment supplier AXT has announced a partnership with atomic force microscope (AFM) manufacturer NT-MDT. The agreement will see AXT represent NT-MDT in Australia and New Zealand, looking after both sales and service. [ + ]

Thanks to support from the Balnaves Foundation, postdoctoral researcher Dr Jennifer Lynch will explore long non-coding RNAs as potential new targets for treating childhood leukaemia.

The finding that certain peptides have highly neuroprotective properties in stroke models may lead to a treatment that limits brain damage after stroke.